
### [NCIT:C128043](http://purl.obolibrary.org/obo/NCIT_C128043)
**Label:** Cervical Low Grade Neuroendocrine Tumor, Grade 1

**Subclasses:** 

**Class expressions from DL-Learner:**

- [NCIT:C28077](http://purl.obolibrary.org/obo/NCIT_C28077) (Grade 1) 53.85%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C36855](http://purl.obolibrary.org/obo/NCIT_C36855) (Malignant Neuroendocrine Polygonal Cell))) 53.85%
- Thing 52.89%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) 39.20%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 39.20%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 39.20%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 39.20%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 39.20%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 39.20%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 39.20%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 39.20%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant))) 39.20%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C39880](http://purl.obolibrary.org/obo/NCIT_C39880) (Acinar Prostate Adenocarcinoma, Atrophic Variant))) 39.20%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C39875](http://purl.obolibrary.org/obo/NCIT_C39875) (Loss of Chromosome 9q))) 39.20%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C39874](http://purl.obolibrary.org/obo/NCIT_C39874) (Urethral Verrucous Carcinoma))) 39.20%


